Correlation Between Senti Biosciences and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Senti Biosciences and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Senti Biosciences and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Senti Biosciences and Inozyme Pharma, you can compare the effects of market volatilities on Senti Biosciences and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Senti Biosciences with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Senti Biosciences and Inozyme Pharma.
Diversification Opportunities for Senti Biosciences and Inozyme Pharma
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Senti and Inozyme is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Senti Biosciences and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Senti Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Senti Biosciences are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Senti Biosciences i.e., Senti Biosciences and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Senti Biosciences and Inozyme Pharma
Given the investment horizon of 90 days Senti Biosciences is expected to generate 0.85 times more return on investment than Inozyme Pharma. However, Senti Biosciences is 1.18 times less risky than Inozyme Pharma. It trades about 0.01 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.53 per unit of risk. If you would invest 217.00 in Senti Biosciences on September 1, 2024 and sell it today you would lose (1.00) from holding Senti Biosciences or give up 0.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Senti Biosciences vs. Inozyme Pharma
Performance |
| Timeline |
| Senti Biosciences |
| Inozyme Pharma |
Senti Biosciences and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Senti Biosciences and Inozyme Pharma
The main advantage of trading using opposite Senti Biosciences and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Senti Biosciences position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |